Are the UK's vitamin C recommendations evidence-based? A critical comment.
Level 5 - mechanism / opinion, no new human data
Critical commentary and narrative review of historical trials and guidelines with no systematic synthesis.
PubMed 41424103 · doi:10.1017/S0007114525105941
What was done
This critical commentary reviewed the historical basis of the UK's 1991 adult vitamin C intake recommendation (40 mg/d, derived from the 1953 Sheffield study) compared to international recommendations (such as 90 mg/d for men and 75 mg/d for women in the USA). The authors examined pre-1991 and subsequent trial evidence on clinical outcomes beyond classical scurvy prevention.
What was found
The authors noted that 10 mg/d prevents scurvy and 40 mg/d was selected in the UK to yield higher plasma levels. However, at least six controlled trials published before 1991 demonstrated clinical benefits from vitamin C supplementation in individuals already consuming 40 mg/d or more. Additionally, a 1993 randomized controlled trial in ultramarathon runners observed benefits even at baseline intakes of approximately 500 mg/d. The abstract reported no pooled effect sizes or numerical outcome data.
Why it matters
The paper argues that UK vitamin C guidelines are outdated and understate dietary requirements by focusing exclusively on dermatological scurvy rather than non-scurvy outcomes like respiratory infection morbidity and cardiac dysfunction.
Limits
As a narrative commentary, this paper does not use systematic review methodology or report quantitative synthesis. Detailed outcome measures, sample sizes, and effect sizes from the cited trials are omitted from the abstract, and findings from specialized cohorts (e.g., ultramarathon runners) cannot be generalized to the general public.
Cited by
- supports Consuming less than 10 milligrams of vitamin C daily causes scurvy.